Published in the journal Psychological Medicine, their new study is the first to demonstrate that a single dose of CBD may partially boost activity in two parts of the brain, the prefrontal, and mediotemporal cortices, in people with established psychosis. To source their results, the research group gave 13 people, who had all been diagnosed with psychosis, one 600mg CBD capsule each. After a few hours, every participant underwent a word association memory test while their brain was scanned with a functional magnetic resonance imaging (fMRI) machine. To act as a control group, 19 other participants were also scanned under identical conditions, but without any drug administration. The researchers found that when the participants with psychosis were given the dose of CBD, the activation in their prefrontal and mediotemporal brain areas became more like the activation seen in the control group. These brain regions are often associated with decision making and conscious memory, and their over- and under-activation have been reported in individuals with schizophrenia, as well as in those at risk. Study: https://www.cambridge.org/core/journals/psychological-medicine/article/normalization-of-mediotemporal-and-prefrontal-activity-and-mediotemporalstriatal-connectivity-may-underlie-antipsychotic-effects-of-cannabidiol-in-psychosis/6571F47CE15D05DC50782A7BB7C00A7F Full pdf magazine article: https://cdn2.hubspot.net/hubfs/547446/Technology%20Networks/TN%20Editorial%20Calendar/Analytical%20Cannabis%20Monthly%20Digest/2020/February/Final_AC_February%20Digest-1.pdf #cbd #psychosis #brainpower #cbdresearch #hempresearch #cbdhow #cbdreviews #cbdresearch #hempresearch #cannaeducation #cbdeducationonline #cbdeducate #cbdeducation #hempeducation #cbdnews #cbdinformation #psychosisawareness #brainrecovery #mentalhealth #mentalhealthawareness #mentalhealthmatters #mentalhealthadvocate (at University of Cambridge) https://www.instagram.com/p/B9m2A3MBKK7/?igshid=jkg9fcanrkgy
